Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Elutia Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 29 | 32 | +3 |
| Shares | 12.2M | 13.2M | +994.4K (+8.2%) |
| Value | $46.7M | $49.3M | +$2.59M (+5.6%) |
New holders (7)
Institutions that held Elutia Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 683 Capital Management, LLC | 80,758 | $302.0K | 0.03% |
| Citadel Advisors LLC | 22,431 | $83.9K | 0.00% |
| Susquehanna International Group, LLP | 16,949 | $63.4K | 0.00% |
| State Street Corp | 11,969 | $44.8K | 0.00% |
| UBS Group AG | 3,831 | $14.3K | 0.00% |
| BNP Paribas Arbitrage, SA | 387 | $1.45K | 0.00% |
| SBI Securities Co., Ltd. | 55 | $206 | 0.00% |
Sold out (4)
Institutions that held Elutia Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| EAM Investors, LLC | 122,260 | $465.8K |
| Arcus Capital Partners, LLC | 20,000 | $76.2K |
| Worth Venture Partners, LLC | 15,000 | $57.1K |
| Federated Hermes, Inc. | 342 | $1.30K |